<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117053">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01579214</url>
  </required_header>
  <id_info>
    <org_study_id>CP-002</org_study_id>
    <secondary_id>R24TW007988</secondary_id>
    <nct_id>NCT01579214</nct_id>
  </id_info>
  <brief_title>Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda</brief_title>
  <official_title>Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mbarara University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>John E. Fogarty International Center (FIC)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harvard University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will study the efficacy of a novel cellular phone messaging system to
      communicate health information and facilitate early return to clinic after abnormal
      laboratory results in rural Uganda.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Among the challenges that complicate optimal health care delivery in rural settings is lack
      of communication between care providers and patients. Communication of abnormal laboratory
      results represents a particular challenge. Laboratory and other test results are often not
      reported until repeat visits weeks to months later. In the case of treatment failure, severe
      treatment complications, or evidence of opportunistic infection, such reporting delays
      likely result in adverse outcomes and potentially compromise future treatment options. The
      investigators propose to evaluate a novel strategy of communication using SMS text messaging
      to facilitate patient return to an HIV clinic in Uganda after critical laboratory results.

      The investigators will consent and enroll participants at the time of laboratory testing for
      CD4 count, viral loads, acid fast bacteria smears of sputum, among others. Those with
      abnormal results will be randomized to various messaging formats and receive text messages
      requesting a prompt return to clinic. For outcomes, the investigators will measure
      successful receipt and comprehension of messages, as well as proportion returning within 14
      days of the abnormal laboratory test.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Receipt and comprehension of health-related text message</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Return to clinic</measure>
    <time_frame>14 days from test result</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">540</enrollment>
  <condition>HIV</condition>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>Direct Text Message</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Direct Text Message+PIN-code activation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Coded Text Message</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cellular Phone Text Message Formats</intervention_name>
    <description>Cellular phone text message formats to be sent to participants after abnormal laboratory results to communicate information and request early return to clinic.</description>
    <arm_group_label>Direct Text Message</arm_group_label>
    <arm_group_label>Direct Text Message+PIN-code activation</arm_group_label>
    <arm_group_label>Coded Text Message</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV positive

          -  Active in care at Mbarara Regional Referral Hospital HIV Clinic

          -  Undergoing laboratory testing

          -  Self-reported cell phone access

          -  Agrees to participation and gives informed consent

        Exclusion Criteria:

          -  Age &lt; 18

          -  Resides outside great Mbarara area (Mbarara, Isingiro, Kyruhuura, Ibanda, or Ntungamo
             districts)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Siedner, MD MPH</last_name>
    <role>Study Director</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bosco Bwana, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mbarara University of Science and Technology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David R Bangsberg, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital Center for Global Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jessica Haberer, MD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital Center for Global Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ISS Clinic, Mbarara Regional Referral Hospital</name>
      <address>
        <city>Mbarara</city>
        <country>Uganda</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <lastchanged_date>April 10, 2015</lastchanged_date>
  <firstreceived_date>April 13, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>David Bangsberg, MD</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Africa south of the sahara</keyword>
  <keyword>Knowledge of results</keyword>
  <keyword>Communication barriers</keyword>
  <keyword>Cellular Phones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
